{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T03:38:24Z","timestamp":1792726704723,"version":"4.5.0"},"reference-count":50,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100000191","name":"Kidney Foundation of Canada","doi-asserted-by":"publisher","award":["851937-21KHRG"],"award-info":[{"award-number":["851937-21KHRG"]}],"id":[{"id":"10.13039\/501100000191","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000191","name":"Kidney Foundation of Canada","doi-asserted-by":"publisher","award":["24KHRG-1251453"],"award-info":[{"award-number":["24KHRG-1251453"]}],"id":[{"id":"10.13039\/501100000191","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000035","name":"Institute of Nutrition Metabolism and Diabetes","doi-asserted-by":"publisher","award":["PJT-198110"],"award-info":[{"award-number":["PJT-198110"]}],"id":[{"id":"10.13039\/501100000035","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000035","name":"Institute of Nutrition Metabolism and Diabetes","doi-asserted-by":"publisher","award":["PJT-175027"],"award-info":[{"award-number":["PJT-175027"]}],"id":[{"id":"10.13039\/501100000035","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["akdh.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Advances in Kidney Disease and Health"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1053\/j.akdh.2026.04.001","type":"journal-article","created":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T20:33:38Z","timestamp":1783024418000},"page":"135-142","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Primary Aldosteronism and the Kidneys"],"prefix":"10.1053","volume":"33","author":[{"given":"Emily L.","family":"Simms","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3559-3531","authenticated-orcid":false,"given":"Gregory L.","family":"Hundemer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"16","key":"10.1053\/j.akdh.2026.04.001_bib1","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1016\/j.jacc.2020.02.052","article-title":"Primary aldosteronism in patients in China with recently detected hypertension","volume":"75","author":"Xu","year":"2020","journal-title":"J Am Coll Cardiol"},{"issue":"14","key":"10.1053\/j.akdh.2026.04.001_bib2","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1016\/j.jacc.2017.01.052","article-title":"Prevalence and clinical manifestations of primary aldosteronism encountered in primary care practice","volume":"69","author":"Monticone","year":"2017","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"10.1053\/j.akdh.2026.04.001_bib3","doi-asserted-by":"crossref","first-page":"10","DOI":"10.7326\/M20-0065","article-title":"The unrecognized prevalence of primary aldosteronism: a cross-sectional study","volume":"173","author":"Brown","year":"2020","journal-title":"Ann Intern Med"},{"issue":"3","key":"10.1053\/j.akdh.2026.04.001_bib4","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1097\/MNH.0000000000000702","article-title":"How common is primary aldosteronism?","volume":"30","author":"Hundemer","year":"2021","journal-title":"Curr Opin Nephrol Hypertens"},{"issue":"3","key":"10.1053\/j.akdh.2026.04.001_bib5","doi-asserted-by":"crossref","first-page":"289","DOI":"10.7326\/M20-4873","article-title":"Testing for primary aldosteronism and mineralocorticoid receptor antagonist use among U.S. veterans: a retrospective cohort study","volume":"174","author":"Cohen","year":"2021","journal-title":"Ann Intern Med"},{"issue":"1","key":"10.1053\/j.akdh.2026.04.001_bib6","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1161\/HYPERTENSIONAHA.121.18118","article-title":"Screening rates for primary aldosteronism among individuals with hypertension plus hypokalemia: a population-based retrospective cohort study","volume":"79","author":"Hundemer","year":"2022","journal-title":"Hypertension"},{"issue":"1","key":"10.1053\/j.akdh.2026.04.001_bib7","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1210\/endrev\/bnad024","article-title":"Biomarkers to guide medical therapy in primary aldosteronism","volume":"45","author":"Hundemer","year":"2024","journal-title":"Endocr Rev"},{"issue":"4","key":"10.1053\/j.akdh.2026.04.001_bib8","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.ecl.2019.08.002","article-title":"Primary aldosteronism diagnosis and management: a clinical approach","volume":"48","author":"Hundemer","year":"2019","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"5","key":"10.1053\/j.akdh.2026.04.001_bib9","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1210\/jc.2015-4061","article-title":"The management of primary aldosteronism: case detection, diagnosis, and treatment: an Endocrine Society Clinical Practice guideline","volume":"101","author":"Funder","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.1053\/j.akdh.2026.04.001_bib10","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S2213-8587(17)30319-4","article-title":"Cardiovascular events and target organ damage in primary aldosteronism compared with essential hypertension: a systematic review and meta-analysis","volume":"6","author":"Monticone","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"1","key":"10.1053\/j.akdh.2026.04.001_bib11","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S2213-8587(17)30367-4","article-title":"Cardiometabolic outcomes and mortality in medically treated primary aldosteronism: a retrospective cohort study","volume":"6","author":"Hundemer","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"8","key":"10.1053\/j.akdh.2026.04.001_bib12","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1001\/jamacardio.2018.2003","article-title":"Incidence of atrial fibrillation and mineralocorticoid receptor activity in patients with medically and surgically treated primary aldosteronism","volume":"3","author":"Hundemer","year":"2018","journal-title":"JAMA Cardiol"},{"issue":"3","key":"10.1053\/j.akdh.2026.04.001_bib13","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1161\/HYPERTENSIONAHA.118.11568","article-title":"Renal outcomes in medically and surgically treated primary aldosteronism","volume":"72","author":"Hundemer","year":"2018","journal-title":"Hypertension"},{"issue":"22","key":"10.1053\/j.akdh.2026.04.001_bib14","doi-asserted-by":"crossref","first-page":"2638","DOI":"10.1001\/jama.295.22.2638","article-title":"Long-term renal outcomes in patients with primary aldosteronism","volume":"295","author":"Sechi","year":"2006","journal-title":"JAMA"},{"issue":"1","key":"10.1053\/j.akdh.2026.04.001_bib15","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/HJH.0000000000002216","article-title":"Renal damage in primary aldosteronism: a systematic review and meta-analysis","volume":"38","author":"Monticone","year":"2020","journal-title":"J Hypertens"},{"issue":"5","key":"10.1053\/j.akdh.2026.04.001_bib16","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1681\/ASN.2004100878","article-title":"Relative glomerular hyperfiltration in primary aldosteronism","volume":"16","author":"Ribstein","year":"2005","journal-title":"J Am Soc Nephrol"},{"issue":"9","key":"10.1053\/j.akdh.2026.04.001_bib17","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1210\/clinem\/dgaf284","article-title":"Primary aldosteronism: an Endocrine Society Clinical Practice guideline","volume":"110","author":"Adler","year":"2025","journal-title":"J Clin Endocrinol Metab"},{"issue":"38","key":"10.1053\/j.akdh.2026.04.001_bib18","doi-asserted-by":"crossref","first-page":"3912","DOI":"10.1093\/eurheartj\/ehae178","article-title":"2024 ESC guidelines for the management of elevated blood pressure and hypertension","volume":"45","author":"McEvoy","year":"2024","journal-title":"Eur Heart J"},{"issue":"8","key":"10.1053\/j.akdh.2026.04.001_bib19","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1210\/clinem\/dgab348","article-title":"Performance of the aldosterone to renin ratio as a screening test for primary aldosteronism","volume":"106","author":"Hung","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"10.1053\/j.akdh.2026.04.001_bib20","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1161\/HYPERTENSIONAHA.120.16429","article-title":"Intraindividual variability of aldosterone concentrations in primary aldosteronism: implications for case detection","volume":"77","author":"Yozamp","year":"2021","journal-title":"Hypertension"},{"issue":"1","key":"10.1053\/j.akdh.2026.04.001_bib21","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1210\/clinem\/dgac568","article-title":"Aldosterone, renin, and aldosterone-to-renin ratio variability in screening for primary aldosteronism","volume":"108","author":"Ng","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"10.1053\/j.akdh.2026.04.001_bib22","doi-asserted-by":"crossref","first-page":"2072","DOI":"10.1161\/HYPERTENSIONAHA.124.22884","article-title":"Comparing ARR versus suppressed PRA as screening tests for primary aldosteronism","volume":"81","author":"Marcelli","year":"2024","journal-title":"Hypertension"},{"issue":"8","key":"10.1053\/j.akdh.2026.04.001_bib23","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1161\/CIRCULATIONAHA.118.033597","article-title":"Primary aldosteronism: practical approach to diagnosis and management","volume":"138","author":"Byrd","year":"2018","journal-title":"Circulation"},{"issue":"6","key":"10.1053\/j.akdh.2026.04.001_bib24","doi-asserted-by":"crossref","first-page":"680","DOI":"10.4158\/EP161717.RA","article-title":"An individualized approach to the evaluation and management of primary aldosteronism","volume":"23","author":"Vaidya","year":"2017","journal-title":"Endocr Pract"},{"issue":"5","key":"10.1053\/j.akdh.2026.04.001_bib25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1161\/JAHA.117.005574","article-title":"Quantitative value of aldosterone-renin ratio for detection of aldosterone-producing adenoma: the aldosterone-renin ratio for primary aldosteronism (AQUARR) study","volume":"6","author":"Maiolino","year":"2017","journal-title":"J Am Heart Assoc"},{"issue":"8","key":"10.1053\/j.akdh.2026.04.001_bib26","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1161\/HYPERTENSIONAHA.122.19377","article-title":"Performance of confirmatory tests for diagnosing primary aldosteronism: a systematic review and meta-analysis","volume":"79","author":"Leung","year":"2022","journal-title":"Hypertension"},{"issue":"2","key":"10.1053\/j.akdh.2026.04.001_bib27","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1210\/clinem\/dgac654","article-title":"Exclusion tests in unilateral primary aldosteronism (ExcluPA) study","volume":"108","author":"Zhu","year":"2023","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"10.1053\/j.akdh.2026.04.001_bib28","doi-asserted-by":"crossref","first-page":"329","DOI":"10.7326\/0003-4819-151-5-200909010-00007","article-title":"Systematic review: diagnostic procedures to differentiate unilateral from bilateral adrenal abnormality in primary aldosteronism","volume":"151","author":"Kempers","year":"2009","journal-title":"Ann Intern Med"},{"issue":"6","key":"10.1053\/j.akdh.2026.04.001_bib29","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1111\/cen.13442","article-title":"Discordance between imaging and immunohistochemistry in unilateral primary aldosteronism","volume":"87","author":"Nanba","year":"2017","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"6","key":"10.1053\/j.akdh.2026.04.001_bib30","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1016\/j.surg.2004.06.051","article-title":"Role for adrenal venous sampling in primary aldosteronism","volume":"136","author":"Young","year":"2004","journal-title":"Surgery"},{"issue":"4","key":"10.1053\/j.akdh.2026.04.001_bib31","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1210\/endrev\/bnaf007","article-title":"Subtyping of primary aldosteronism by adrenal venous sampling","volume":"46","author":"Rossi","year":"2025","journal-title":"Endocr Rev"},{"issue":"2","key":"10.1053\/j.akdh.2026.04.001_bib32","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S2213-8587(24)00308-5","article-title":"Outcomes after medical treatment for primary aldosteronism: an international consensus and analysis of treatment response in an international cohort","volume":"13","author":"Yang","year":"2025","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"7","key":"10.1053\/j.akdh.2026.04.001_bib33","doi-asserted-by":"crossref","DOI":"10.1111\/obr.13450","article-title":"Obesity-related glomerulopathy: current approaches and future perspectives","volume":"23","author":"Martinez-Montoro","year":"2022","journal-title":"Obes Rev"},{"issue":"4","key":"10.1053\/j.akdh.2026.04.001_bib34","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1681\/ASN.2016060666","article-title":"Glomerular hyperfiltration in diabetes: mechanisms, clinical significance, and treatment","volume":"28","author":"Tonneijck","year":"2017","journal-title":"J Am Soc Nephrol"},{"issue":"5","key":"10.1053\/j.akdh.2026.04.001_bib35","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/nrneph.2012.19","article-title":"Glomerular hyperfiltration: definitions, mechanisms and clinical implications","volume":"8","author":"Helal","year":"2012","journal-title":"Nat Rev Nephrol"},{"issue":"10","key":"10.1053\/j.akdh.2026.04.001_bib36","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1093\/ajh\/hpae084","article-title":"Primary aldosteronism and kidney hemodynamics: adding another piece to the puzzle","volume":"37","author":"Hundemer","year":"2024","journal-title":"Am J Hypertens"},{"issue":"12","key":"10.1053\/j.akdh.2026.04.001_bib37","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1097\/00004872-199612000-00013","article-title":"High sodium sensitivity and glomerular hypertension\/hyperfiltration in primary aldosteronism","volume":"14","author":"Kimura","year":"1996","journal-title":"J Hypertens"},{"issue":"10","key":"10.1053\/j.akdh.2026.04.001_bib38","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1093\/ajh\/hpae071","article-title":"Association between plasma aldosterone concentration and intraglomerular hemodynamics in primary aldosteronism","volume":"37","author":"Uedono","year":"2024","journal-title":"Am J Hypertens"},{"issue":"9","key":"10.1053\/j.akdh.2026.04.001_bib39","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1161\/HYPERTENSIONAHA.123.21096","article-title":"Association of reversal of renin suppression with long-term renal outcome in medically treated primary aldosteronism","volume":"80","author":"Katsuragawa","year":"2023","journal-title":"Hypertension"},{"issue":"3","key":"10.1053\/j.akdh.2026.04.001_bib40","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1161\/HYPERTENSIONAHA.119.13131","article-title":"Association between acute fall in estimated glomerular filtration rate after treatment for primary aldosteronism and long-term decline in renal function","volume":"74","author":"Kobayashi","year":"2019","journal-title":"Hypertension"},{"issue":"8","key":"10.1053\/j.akdh.2026.04.001_bib41","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1016\/j.ekir.2020.06.012","article-title":"Associations between changes in plasma renin activity and aldosterone concentrations and changes in kidney function after treatment for primary aldosteronism","volume":"5","author":"Kobayashi","year":"2020","journal-title":"Kidney Int Rep"},{"issue":"9","key":"10.1053\/j.akdh.2026.04.001_bib42","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/S2213-8587(17)30135-3","article-title":"Outcomes after adrenalectomy for unilateral primary aldosteronism: an international consensus on outcome measures and analysis of remission rates in an international cohort","volume":"5","author":"Williams","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"1","key":"10.1053\/j.akdh.2026.04.001_bib43","doi-asserted-by":"crossref","DOI":"10.1210\/jendso\/bvab174","article-title":"Increased dosage of MRA improves BP and urinary albumin excretion in primary aldosteronism with suppressed plasma renin","volume":"6","author":"Saiki","year":"2022","journal-title":"J Endocr Soc"},{"issue":"5","key":"10.1053\/j.akdh.2026.04.001_bib44","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1161\/HYPERTENSIONAHA.121.16498","article-title":"Genetics of primary aldosteronism","volume":"79","author":"Scholl","year":"2022","journal-title":"Hypertension"},{"issue":"3","key":"10.1053\/j.akdh.2026.04.001_bib45","doi-asserted-by":"crossref","first-page":"336","DOI":"10.7326\/ANNALS-24-00761","article-title":"Molecular imaging versus adrenal vein sampling for the detection of surgically curable primary aldosteronism : a prospective within-patient trial","volume":"178","author":"Goodchild","year":"2025","journal-title":"Ann Intern Med"},{"issue":"5","key":"10.1053\/j.akdh.2026.04.001_bib46","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1056\/NEJMc2508629","article-title":"Phase 2a study of baxdrostat in primary aldosteronism","volume":"399","author":"Turcu","year":"2025","journal-title":"N Engl J Med"},{"issue":"9","key":"10.1053\/j.akdh.2026.04.001_bib47","doi-asserted-by":"crossref","first-page":"630","DOI":"10.7326\/M17-0882","article-title":"The spectrum of subclinical primary aldosteronism and incident hypertension: a cohort study","volume":"167","author":"Brown","year":"2017","journal-title":"Ann Intern Med"},{"issue":"13","key":"10.1053\/j.akdh.2026.04.001_bib48","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1161\/CIRCULATIONAHA.124.073507","article-title":"Subclinical primary aldosteronism and major adverse cardiovascular events: a longitudinal population-based cohort study","volume":"152","author":"Goupil","year":"2025","journal-title":"Circulation"},{"issue":"2","key":"10.1053\/j.akdh.2026.04.001_bib49","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1161\/CIRCULATIONAHA.123.066389","article-title":"Subclinical primary aldosteronism and cardiovascular health: a population-based cohort study","volume":"149","author":"Hundemer","year":"2024","journal-title":"Circulation"},{"key":"10.1053\/j.akdh.2026.04.001_bib50","doi-asserted-by":"crossref","DOI":"10.1681\/ASN.0000001039","article-title":"Subclinical primary aldosteronism and eGFR decline over time","author":"Hundemer","year":"2026","journal-title":"J Am Soc Nephrol"}],"container-title":["Advances in Kidney Disease and Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949813926000650?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949813926000650?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T03:00:22Z","timestamp":1792724422000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2949813926000650"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":50,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S2949813926000650"],"URL":"https:\/\/doi.org\/10.1053\/j.akdh.2026.04.001","relation":{},"ISSN":["2949-8139"],"issn-type":[{"value":"2949-8139","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Primary Aldosteronism and the Kidneys","name":"articletitle","label":"Article Title"},{"value":"Advances in Kidney Disease and Health","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.akdh.2026.04.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 by the National Kidney Foundation, Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}